Difficulty: Medium
Average Score: 78%
Practice
The most important reason for using a combination of chemotherapeutic agents in the treatment of tuberculosis is
Correct answer
B
Rationale
In the treatment of tuberculosis, using a combination of chemotherapeutic agents is essential to prevent the development of resistance to the drugs. Tuberculosis is caused by Mycobacterium tuberculosis, a bacterium that can quickly develop resistance to single drugs through mutations. By using a combination of drugs, each with a different mechanism of action, the likelihood of the bacteria developing resistance is significantly reduced. This approach, known as combination therapy, is a cornerstone of tuberculosis treatment to ensure the effectiveness of the drugs over the course of the treatment.
Option A, to obtain a bactericidal effect, is not the most important reason for using a combination of drugs in tuberculosis treatment. While achieving a bactericidal effect is important, preventing the development of drug resistance takes precedence due to the high risk of resistance in tuberculosis.
Option C, to broaden the spectrum of activity, is not the primary reason for using combination therapy in tuberculosis. Tuberculosis is caused by a specific bacterium, and the focus is on preventing resistance rather than broadening the spectrum of activity.
Option D, to reduce adverse effects of the drugs, is not the main rationale for using combination therapy in tuberculosis. While reducing adverse effects is important, the primary goal is to ensure the effectiveness of the treatment by preventing resistance.
Educationally, understanding the rationale behind using combination therapy in tuberculosis treatment is crucial for healthcare professionals, especially those preparing for exams like the NCLEX. It highlights the importance of strategic drug combinations to combat resistant strains of bacteria effectively. This knowledge can inform clinical decision-making and improve patient outcomes in the management of tuberculosis and other infectious diseases.
Option A, to obtain a bactericidal effect, is not the most important reason for using a combination of drugs in tuberculosis treatment. While achieving a bactericidal effect is important, preventing the development of drug resistance takes precedence due to the high risk of resistance in tuberculosis.
Option C, to broaden the spectrum of activity, is not the primary reason for using combination therapy in tuberculosis. Tuberculosis is caused by a specific bacterium, and the focus is on preventing resistance rather than broadening the spectrum of activity.
Option D, to reduce adverse effects of the drugs, is not the main rationale for using combination therapy in tuberculosis. While reducing adverse effects is important, the primary goal is to ensure the effectiveness of the treatment by preventing resistance.
Educationally, understanding the rationale behind using combination therapy in tuberculosis treatment is crucial for healthcare professionals, especially those preparing for exams like the NCLEX. It highlights the importance of strategic drug combinations to combat resistant strains of bacteria effectively. This knowledge can inform clinical decision-making and improve patient outcomes in the management of tuberculosis and other infectious diseases.